IB

iBio

IBIO
NYSE MKT LLCHealth Care

Recent Patents

ibio
1 year ago

Filed a patent for "high-efficiency, conditionally-activated antibody discovery and masked antibodies" on Fri, August 25, 2023

New US Patent
ibio
over 1 year ago

Filed a patent for "trop2 antibodies" on Mon, June 5, 2023

New US Patent
ibio
over 1 year ago

Filed a patent for "trop2 antibodies" on Tue, July 25, 2023

New US Patent
ibio
over 1 year ago

Filed a patent for "anti-cd3 antibodies" on Fri, March 31, 2023

New US Patent
ibio
over 1 year ago

Filed a patent for "anti-cd3 antibodies" on Thu, October 3, 2024

New US Patent
ibio
over 1 year ago

Filed a patent for "anti-muc16 antibodies" on Mon, February 6, 2023

New US Patent
ibio
over 1 year ago

Filed a patent for "anti-muc16 antibodies" on Thu, August 8, 2024

New US Patent
ibio
almost 2 years ago

Filed a patent for "machine learning method for protein modelling to design engineered peptides" on Thu, March 30, 2023

New US Patent
ibio
almost 2 years ago

Filed a patent for "epidermal growth factor receptor variant iii antibodies" on Tue, October 11, 2022

New US Patent
ibio
almost 2 years ago

Filed a patent for "chemokine receptor 8 (ccr8) antibodies" on Wed, October 19, 2022

New US Patent
ibio
almost 2 years ago

Filed a patent for "generalized scaffolds for polypeptide display and uses thereof" on Thu, March 21, 2024

New US Patent
ibio
almost 2 years ago

Filed a patent for "pd-1 agonist antibodies" on Tue, July 25, 2023

New US Patent
ibio
almost 2 years ago

Filed a patent for "epidermal growth factor receptor variant iii antibodies" on Tue, July 25, 2023

New US Patent
ibio
almost 2 years ago

Filed a patent for "chemokine receptor 8 (ccr8) antibodies" on Fri, August 11, 2023

New US Patent
ibio
almost 2 years ago

Filed a patent for "pd-1 agonist antibodies" on Thu, March 21, 2024

New US Patent
ibio
almost 2 years ago

Filed a patent for "epidermal growth factor receptor variant iii antibodies" on Thu, April 11, 2024

New US Patent
ibio
almost 2 years ago

Filed a patent for "chemokine receptor 8 (ccr8) antibodies" on Thu, April 25, 2024

New US Patent
ibio
2 years ago

Filed a patent for "pd-1 agonist antibodies" on Wed, September 14, 2022

New US Patent
ibio
2 years ago

Filed a patent for "sars-cov-2 subunit and variant vaccines" on Thu, November 24, 2022

New US Patent
ibio
2 years ago

Filed a patent for "anti-cd-25 antibody" on Fri, May 6, 2022

New US Patent
ibio
2 years ago

Filed a patent for "anti-cd-25 antibody" on Thu, May 25, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...